• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biometrics . Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections

tetano

Editor, Senior Moderator
Biometrics

. 2026 Oct 7;82(4):ujag162.
doi: 10.1093/biomtc/ujag162.

Estimating the duration of RT-PCR positivity for SARS-CoV-2 from doubly interval censored data with undetected infections​


Joshua Blake 1 , Paul Birrell 1 2 , A Sarah Walker 3 4 5 , Koen B Pouwels 6 5 , Thomas House 7 , Brian D M Tom 1 , Theodore Kypraios 8 , Daniela De Angelis 1 2

Affiliations Expand


Abstract​


Monitoring the incidence of new infections during a pandemic is critical for an effective public health response. General population prevalence surveys for SARS-CoV-2 can provide high-quality data to estimate incidence. However, estimation relies on understanding the distribution of the duration that infections remain detectable. This study addresses this need using data from the Coronavirus Infection Survey (CIS), a long-term, longitudinal, general population survey conducted in the United Kingdom. Analyzing these data presents unique challenges, such as double interval censoring, undetected infections, and false negatives. We propose a Bayesian nonparametric survival analysis approach, estimating a discrete-time distribution of durations and integrating prior information derived from a complementary study. Our methodology is validated through a simulation study, including its resilience to model misspecification, and then applied to the CIS dataset. This results in the first estimate of the full duration distribution in a general population, as well as methodology that could be transferred to new contexts.

Keywords: Bayesian methods; false negatives; lifetime and survival analysis; misclassification.
 
Back
Top Bottom